Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
MB-105 by March Biosciences for Peripheral T-Cell Lymphomas (PTCL): Likelihood of Approval
MB-105 is under clinical development by March Biosciences and currently in Phase I for Peripheral T-Cell Lymphomas (PTCL). According to...
Data Insights
MB-105 by March Biosciences for Anaplastic Large Cell Lymphoma (ALCL): Likelihood of Approval
MB-105 is under clinical development by March Biosciences and currently in Phase I for Anaplastic Large Cell Lymphoma (ALCL). According...